A study published in JAMA Internal Medicine reveals that the Trump administration’s funding cuts to biomedical research resulted in the cancellation of at least 383 clinical trials, affecting over 74,000 participants. Led by Harvard researchers, the study highlights the inefficiencies and ethical violations stemming from the $1.8 billion in grants terminated by the National Institutes of Health in March. The research utilized an NIH database and accountability tracking tools to assess the impact of these cuts. The findings underscore the significant harm caused to ongoing clinical research and patient care.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
